SEC reporting owner

Broadfin Healthcare Master Fund Ltd SEC insider disclosures

Explore Broadfin Healthcare Master Fund Ltd's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001511900
Issuers
12
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

STRATA Skin Sciences, Inc.0001051514MELA, SSKNNoNo
PROGENICS PHARMACEUTICALS INC0000835887PGNXNoNo
Recro Pharma, Inc.0001588972REPHNoNo
Retrophin, Inc.0001438533RTRXNoNo
CARDICA INC0001178104CRDCNoNo
Aegerion Pharmaceuticals, Inc.0001338042AEGRNoNo
NOVELION THERAPEUTICS INC.0000827809NVLN, NVLNFNoYes
AVADEL PHARMACEUTICALS PLC0001012477AVDLNoYes
ARATANA THERAPEUTICS, INC.0001509190PETXNoNo
Corium International, Inc.0001594337CORINoNo
Mirati Therapeutics, Inc.0001576263MRTXNoNo
BIODELIVERY SCIENCES INTERNATIONAL INC0001103021BDSINoYes

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.